Connor, Clark & Lunn Investment Management (CC&L)’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56,327
| Closed | -$1.28M | – | 1511 |
|
|
2024
Q4 | $1.28M | Sell |
56,327
-178,735
| -76% | -$4.05M | 0.01% | 851 |
|
|
2024
Q3 | $4.27M | Buy |
+235,062
| New | +$4.27M | 0.02% | 480 |
|
|
2024
Q2 | – | Sell |
-32,300
| Closed | -$1.15M | – | 1516 |
|
|
2024
Q1 | $1.15M | Sell |
32,300
-10,366
| -24% | -$367K | ﹤0.01% | 847 |
|
|
2023
Q4 | $1.86M | Sell |
42,666
-9,282
| -18% | -$404K | 0.01% | 684 |
|
|
2023
Q3 | $1.98M | Sell |
51,948
-53,569
| -51% | -$2.05M | 0.01% | 627 |
|
|
2023
Q2 | $4.34M | Buy |
+105,517
| New | +$4.34M | 0.02% | 429 |
|
|
2022
Q3 | – | Sell |
-4,916
| Closed | -$266K | – | 1172 |
|
|
2022
Q2 | $266K | Buy |
+4,916
| New | +$266K | ﹤0.01% | 885 |
|